Efficacy and Safety of Obeticholic Acid in the Treatment of Primary Biliary Cholangitis
Clinical trial NCT05450887 · COMPLETED
Trial details
- NCT number
- NCT05450887
- Sponsor
- Nanjing Chia-tai Tianqing Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-23
- Primary completion
- 2024-03-18
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.